Get more information on Lancet Market - Request Free Sample Report
The Lancet Market Size was valued at USD 2.18 billion in 2023 and is expected to reach USD 4.47 billion by 2032 and grow at a CAGR of 8.33% over the forecast period 2024-2032. This report emphasizes the prevalence and incidence of lancet use, fueled by the growing diabetes burden and expanding self-monitoring behavior. The research analyzes prescription and use patterns by regions, highlighting differences in demand based on healthcare infrastructure and access. It also discusses pricing trends and cost analysis, evaluating manufacturing costs, reimbursement policies, and affordability for various consumer segments. Regulatory and compliance patterns significantly influence market forces, guaranteeing product safety and alignment with international standards. Market trends are witnessing a shift towards pain-free and minimally invasive lancets, with increasing demand for innovative and user-friendly products. The report also provides an assessment of healthcare expenditure on lancets across geographies, examining contributions from government programs, commercial healthcare services, private facilities, and out-of-pocket spending.
Market Dynamics
Drivers
Growing prevalence of diabetes and increasing self-monitoring practices are major drivers of the lancet market.
The growing global prevalence of diabetes, with more than 537 million people living with diabetes across the world, is a major force behind the lancet market since regular blood glucose measurement demands the use of lancets. The growing use of self-monitoring blood glucose (SMBG) devices by diabetic patients has considerably increased demand for easy-to-use and painless lancets. Also, the growth of point-of-care testing (POCT) for infectious diseases, cholesterol testing, and anemia testing has boosted the application of lancets in diagnostic testing. Advances in technology, including ultra-thin needles and push-button safety lancets, are fueling consumer demand for less painful blood draws. Demand for safety lancets, which minimize the risk of needlestick injury and cross-contamination, is also on the rise in hospitals and clinics. In addition, rising healthcare spending and programs encouraging preventive medicine, like government-sponsored diabetes campaigns, are fueling increased use of self-testing devices. For example, the Global Diabetes Compact by the WHO hopes to enhance access to necessary diabetes care, like monitoring blood glucose levels, further bolstering growth in the lancet market. Additionally, the growth of e-commerce sites has facilitated greater access to consumers for a vast array of lancet products, driving market growth.
Restraints
High cost of advanced lancets and limited access to healthcare in low-income regions restrict market growth.
The cost of improved safety lancets, which cost more than basic lancets, is still a major issue, especially among lower-income groups. Most push-button or reusable lancets are overpriced because of advancements in technology and therefore less affordable for price-conscious buyers. The absence of adequate reimbursement policies for self-monitoring equipment in many countries also deters people from buying quality lancets. The reliance on traditional blood draws in rural care areas also restrains market penetration. Although greater awareness exists, in developing markets, some health practitioners and patients remain dependent upon cheaper, reusable lancets that increase the possibility of cross-contamination and discourage higher safety features' demand. Another notable restraint is the aversion of some diabetic patients to undertaking frequent self-monitoring out of fear of pain or inconvenience, resulting in lower adoption rates for lancets. Additionally, regulatory strictness for medical devices such as FDA and CE marks presents a hindrance to new market entrants. For instance, meeting ISO 13485 medical device standards raises costs associated with production, which impacts smaller producers. Limited healthcare infrastructure and supply chain disruptions in certain emerging markets also hamper market growth, as access to quality lancets is inconsistent.
Opportunities
Technological advancements and growing demand for home diagnostics present significant opportunities for market expansion.
The growing preference for pain-free and easy-to-use lancets offers a tremendous opportunity for product innovation by manufacturers. The emerging trend of the adoption of minimally invasive blood collection technologies like microneedle-based lancets is projected to transform the market. The rising trend towards personalized medicine and remote patient monitoring is also increasing demand for lancets in home-use diagnostic testing kits. For example, growth in telehealth services is boosting the demand for home-monitoring solutions such as lancets for in-home blood glucose testing. Also, increasing access to healthcare in emerging markets through government programs and NGOs is providing fresh market opportunities. Merging lancets with online health platforms and intelligent monitoring systems can accelerate growth further, with patients demanding intuitive healthcare management solutions. Yet another significant opportunity arises from the rising need for eco-friendly and biodegradable lancets to solve environmental issues related to disposable medical waste. Additionally, growth in online distribution channels and subscription delivery models for diabetes care products is making lancets more available to a larger group of consumers. For instance, businesses such as One Drop and mySugr provide diabetic testing kit subscription delivery plans for home delivery that include lancets, which makes it more convenient for patients. These together provide a good growth scenario for the lancet market.
Challenges
Limited awareness, counterfeit products, and waste management issues pose significant challenges to the lancet market.
In spite of increasing adoption, ignorance about proper lancet usage and self-monitoring is a significant challenge, particularly in developing areas. Several patients fail to conduct frequent blood glucose testing because of poor education on diabetes care, which contributes to reduced demand for lancets. The presence of counterfeit or inferior lancets, especially in unregulated markets, also poses a threat to market growth. Low-quality or fake lancets result in injury, incorrect results, or infections, lowering consumers' confidence in self-monitoring systems. Furthermore, disposal of spent lancets creates an environmental and healthcare burden. Infection risk and needle-stick injury risk are higher when contaminated sharps are improperly disposed of, making waste regulation stricter. Use of specialized sharps disposal units, especially for safety lancets, contributes to increased operational expense for healthcare practitioners.
By Type
In 2023, the Safety Lancet segment commanded the highest market share of more than 55.6% of the overall lancet market. This is fueled by growing focus on patient safety, infection prevention, and needlestick injury prevention, particularly in hospitals and diagnostic laboratories. The broad use of safety lancets in blood glucose monitoring and point-of-care testing also helped them dominate the market.
The Push Button Safety Lancet segment is anticipated to experience the highest growth, led by its simplicity of use, automated activation system, and lower risk of accidental injuries. The increasing need for easy-to-use, single-use lancets, especially in home diagnostics and decentralized healthcare environments, is driving its high adoption. Rising awareness of self-monitoring among diabetic patients is also driving its growth.
By End User
The Hospitals & Clinics segment commanded the largest market share in 2023, accounting for more than 40.3% of the overall lancet market. This is due to the large number of blood tests performed in hospitals, the presence of skilled healthcare workers guaranteeing correct lancet use, and the demand for safety lancets in institutional healthcare settings. The increasing prevalence of chronic diseases such as diabetes and cardiovascular diseases further supported the demand in hospitals and clinics.
The fastest-growing segment is Home Diagnostics, driven by increased adoption of self-monitoring devices for blood glucose and other diagnostic tests. Consumer awareness, the advancement of user-friendly lancet designs, and the shift towards home-based healthcare due to convenience and cost-effectiveness are also driving the rapid expansion of this segment. Increasing e-commerce sales of home-use lancets and government initiatives in promoting self-care further accelerate growth.
Regional Analysis
North America led the world in the lancet market in 2023, holding more than 35% of the overall market share, backed by the high incidence of diabetes, well-established healthcare system, and high adoption of self-monitoring devices. The availability of prominent market players, favorable reimbursement policies, and growing awareness regarding blood glucose monitoring also reinforced the region's dominance. The United States was the largest market share holder, where there was a boost in home diagnostic use and innovation in lancet designs.
Europe was the second-largest market share holder due to an increase in the aging population, an increase in demand for point-of-care testing, and government efforts favoring diabetes management programs. Germany, France, and the UK experienced strong demand due to robust healthcare infrastructure and patient interest in pain-free and safety lancets.
The Asia-Pacific market emerged as the largest-growing market, with growth driven by the growing prevalence of diabetes, increased access to healthcare, and rising awareness of self-monitoring in China, India, and Japan. Increased middle-class population, rising healthcare spending, and the trend towards home diagnostics were major drivers of growth in the market.
Get Customized Report as per your Business Requirement - Request For Customized Report
HTL-STREFA S.A. – Droplet Microneedles, Droplet Safety Lancets, Droplet Personal Lancets
Terumo Corporation – Finetouch Lancets, Capiject Safety Lancets
Becton Dickinson and Company – BD Microtainer Contact-Activated Lancets, BD Safety Lancets
Hoffmann-La Roche Ltd. – Accu-Chek Softclix
Improve Medical Instruments Co. Ltd. – IMI Safety Lancets, IMI Personal Lancets
Bayer AG – MICROLET Lancets
Sarstedt AG & Co. – Sarstedt Safety Lancets, Sarstedt Blood Lancets
Abbott Laboratories – FreeStyle Lancets
Greiner Bio-One International GmbH – Greiner Safety Lancets, Greiner Mini Collect Lancets
Medtronic plc – MiniMed Lancets
Nipro Medical Corporation – TRUEplus Lancets, TRUEdraw Lancing Device
Owen Mumford Ltd. – Unistik 3 Safety Lancets, Unistik Touch Lancets
Ypsomed AG – MyLife Lancets
Arkray Inc. – Glucocard Lancets
Edan Instruments Inc. – Edan Safety Lancets
Recent Developments
In Dec 2024, Terumo Health Outcomes (THO), a unit of Terumo Interventional Systems (TIS), and Medis Medical Imaging, a recognized cardiac imaging software firm, issued a statement today that they have formed a strategic alliance, in the United States, to accelerate cardiovascular care with the use of both ePRISM – the proprietary clinical decision support platform from Terumo – and Medis' Quantitative Flow Ratio (QFR) technology, an non-invasive software solution that is intended for the evaluation of angiography-derived coronary physiology.
| Report Attributes | Details |
| Market Size in 2023 | USD 2.18 billion |
| Market Size by 2032 | USD 4.47 billion |
| CAGR | CAGR of 8.33% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type [Safety Lancet, Push Button Safety Lancet, Pressure Activated Safety Lancet, Personal Lancet] • By End User [Hospitals & Clinics, Diagnostic Centers and Pathology Laboratories, Home Diagnostics, Research and Academic Laboratories] |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | HTL-STREFA S.A., Terumo Corporation, Becton Dickinson and Company, Hoffmann-La Roche Ltd., Improve Medical Instruments Co. Ltd., Bayer AG, Sarstedt AG & Co., Abbott Laboratories, Greiner Bio-One International GmbH, Medtronic plc, Nipro Medical Corporation, Owen Mumford Ltd., Ypsomed AG, Arkray Inc., Edan Instruments Inc. |
Ans: The Lancet Market is expected to grow at a 8.33% CAGR from 2024 to 2032.
Ans: According to our analysis, the Lancet Market is anticipated to reach USD 4.47 billion by 2032.
Ans: The prominent players in the Lancet Market are HTL-STREFA S.A., Terumo Corporation, Becton Dickinson and Company, Hoffmann-La Roche Ltd., Improve Medical Instruments Co. Ltd., Bayer AG, Sarstedt AG & Co., Abbott Laboratories, Greiner Bio-One International GmbH, Medtronic plc, Nipro Medical Corporation, Owen Mumford Ltd., Ypsomed AG, Arkray Inc., Edan Instruments Inc.
Ans: Yes, you may request customization based on your company's needs.
Ans: In 2023, the safety lancet category dominated the market.
Table of content
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence of Lancet Usage (2023)
5.2 Prescription and Usage Trends (2023), by Region
5.3 Pricing Trends and Cost Analysis (2020-2032)
5.4 Regulatory and Compliance Trends (2023-2032)
5.5 Consumer Preferences and Behavioral Trends (2023-2032)
5.6 Healthcare Spending on Lancets, by Region (Government, Commercial, Private, Out-of-Pocket), 2023
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Service Benchmarking
6.3.1 Service specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Service launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Lancet Market Segmentation, by Type
7.1 Chapter Overview
7.2 Safety Lancet
7.2.1 Safety Lancet Market Trends Analysis (2020-2032)
7.2.2 Safety Lancet Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Push Button Safety Lancet
7.3.1 Push Button Safety Lancet Market Trends Analysis (2020-2032)
7.3.2 Push Button Safety Lancet Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Pressure Activated Safety Lancet
7.4.1 Pressure Activated Safety Lancet Market Trends Analysis (2020-2032)
7.4.2 Pressure Activated Safety Lancet Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Personal Lancet
7.5.1 Personal Lancet Market Trends Analysis (2020-2032)
7.5.2 Personal Lancet Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Lancet Market Segmentation, by End User
8.1 Chapter Overview
8.2 Hospitals & Clinics
8.2.1 Hospitals & Clinics Market Trends Analysis (2020-2032)
8.2.2 Hospitals & Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Diagnostic Centers and Pathology Laboratories
8.3.1 Diagnostic Centers and Pathology Laboratories Market Trends Analysis (2020-2032)
8.3.2 Diagnostic Centers and Pathology Laboratories Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Home Diagnostics
8.4.1 Home Diagnostics Market Trends Analysis (2020-2032)
8.4.2 Home Diagnostics Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Research and Academic Laboratories
8.5.1 Research and Academic Laboratories Market Trends Analysis (2020-2032)
8.5.2 Research and Academic Laboratories Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Lancet Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.2.3 North America Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.2.4 North America Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.2.5 USA
9.2.5.1 USA Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.2.5.2 USA Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.2.6 Canada
9.2.6.1 Canada Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.2.6.2 Canada Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.2.7 Mexico
9.2.7.1 Mexico Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.2.7.2 Mexico Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Lancet Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.1.3 Eastern Europe Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.4 Eastern Europe Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.1.5 Poland
9.3.1.5.1 Poland Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.5.2 Poland Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.1.6 Romania
9.3.1.6.1 Romania Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.6.2 Romania Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.7.2 Hungary Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.8.2 Turkey Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.9.2 Rest of Eastern Europe Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Lancet Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.2.3 Western Europe Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.4 Western Europe Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.2.5 Germany
9.3.2.5.1 Germany Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.5.2 Germany Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.2.6 France
9.3.2.6.1 France Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.6.2 France Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.2.7 UK
9.3.2.7.1 UK Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.7.2 UK Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.2.8 Italy
9.3.2.8.1 Italy Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.8.2 Italy Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.2.9 Spain
9.3.2.9.1 Spain Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.9.2 Spain Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.10.2 Netherlands Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.11.2 Switzerland Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.2.12 Austria
9.3.2.12.1 Austria Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.12.2 Austria Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.13.2 Rest of Western Europe Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Lancet Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.4.3 Asia Pacific Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.4 Asia Pacific Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.4.5 China
9.4.5.1 China Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.5.2 China Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.4.6 India
9.4.5.1 India Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.5.2 India Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.4.5 Japan
9.4.5.1 Japan Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.5.2 Japan Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.4.6 South Korea
9.4.6.1 South Korea Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.6.2 South Korea Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.4.7 Vietnam
9.4.7.1 Vietnam Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.2.7.2 Vietnam Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.4.8 Singapore
9.4.8.1 Singapore Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.8.2 Singapore Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.4.9 Australia
9.4.9.1 Australia Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.9.2 Australia Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.10.2 Rest of Asia Pacific Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Lancet Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.1.3 Middle East Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.4 Middle East Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.5.1.5 UAE
9.5.1.5.1 UAE Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.5.2 UAE Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.6.2 Egypt Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.7.2 Saudi Arabia Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.8.2 Qatar Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.9.2 Rest of Middle East Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Lancet Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.2.3 Africa Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.2.4 Africa Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.2.5.2 South Africa Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.2.6.2 Nigeria Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Lancet Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.6.3 Latin America Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.6.4 Latin America Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.6.5 Brazil
9.6.5.1 Brazil Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.6.5.2 Brazil Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.6.6 Argentina
9.6.6.1 Argentina Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.6.6.2 Argentina Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.6.7 Colombia
9.6.7.1 Colombia Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.6.7.2 Colombia Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Lancet Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.6.8.2 Rest of Latin America Lancet Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10. Company Profiles
10.1 HTL-STREFA S.A.
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
10.1.4 SWOT Analysis
10.2 Becton Dickinson and Company
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 Terumo Corporation
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 Hoffmann-La Roche Ltd.
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 Improve Medical Instruments Co. Ltd.
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 Bayer AG
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 Abbott Laboratories
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 Greiner Bio-One International GmbH
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 Medtronic plc
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 Nipro Medical Corporation
10.10.1 Company Overview
10.10.2 Financial
10.10.3 Products/ Services Offered
10.10.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Type
Safety Lancet
Push Button Safety Lancet
Pressure Activated Safety Lancet
Personal Lancet
By End User
Hospitals & Clinics
Diagnostic Centers and Pathology Laboratories
Home Diagnostics
Research and Academic Laboratories
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
Non-opioid Pain Patches Market was valued at USD 991.40 million in 2023 and is expected to reach USD 1701.82 million by 2032, growing at a CAGR of 6.22% from 2024-2032.
The mRNA Sequencing Market was valued at USD 3.6 billion in 2023 and is expected to reach USD 7.19 billion by 2032 and grow at a CAGR of 8.0% over the forecast period 2024-2032.
The Albumin Market Size was valued at USD 6.15 billion in 2023, and is expected to reach USD 10.5 billion by 2032, and grow at a CAGR of 6.1% over the forecast period 2024-2032.
The Vitrification Market Size, valued at USD 8.23 billion in 2023, is projected to reach USD 33.04 billion by 2032, growing at a CAGR of 16.75%.
The Foot Orthotic Insoles Market was valued at USD 3.78 Billion in 2023 and projected to reach USD 6.87 Billion by 2032, growing at a 6.93% CAGR.
The Sexual Health Products Market Size was valued at USD 118.83 Billion in 2023, and is expected to reach USD 243.83 Billion by 2032, and grow at a CAGR of 8.71% over the forecast period 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
